ALB vs PTCT · rev $1.74B vs rev $633.1M
Albemarle Corp (ALB) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
ALB currently screens at market cap $8.00B. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the ALB and PTCT stock pages for the full models.
Not investment advice.